Patents Assigned to Chromaxome Corporation
  • Patent number: 5824485
    Abstract: The present invention relates to a novel drug discovery system for generating and screening molecular diversity. The system provides methods for mixing and cloning genetic materials from a plurality of species of organisms in combinatorial gene expression libraries to generate novel metabolic pathways and classes of compounds. The system also involves methods for pre-screening or identifying for host organisms containing a library that are capable of generating such novel pathways and compounds. The host organisms may be useful in drug screening for particular diseases, and in commercial production of compounds of interest. The methods of the invention are also useful in preserving the genomes of organisms that are known or prospective sources of drugs.
    Type: Grant
    Filed: April 24, 1996
    Date of Patent: October 20, 1998
    Assignee: Chromaxome Corporation
    Inventors: Katie A. Thompson, Lyndon M. Foster, Todd C. Peterson, Nicole Marie Nasby, Paul Brian
  • Patent number: 5783431
    Abstract: The present invention relates to a novel drug discovery system for generating and screening molecular diversity. The system provides methods for mixing and cloning genetic materials from a plurality of species of organisms in combinatorial gene expression libraries to generate novel metabolic pathways and classes of compounds. The system also provides mobilizable combinatorial gene expression libraries that can be transferred from one species of host organism to another for expression. Also provided are specialized cloning vectors for making mobilizable gene expression libraries. The system also involves methods for pre-screening or identifying for host organisms containing a library that are capable of generating such novel pathways and compounds.
    Type: Grant
    Filed: October 24, 1996
    Date of Patent: July 21, 1998
    Assignee: Chromaxome Corporation
    Inventors: Todd C. Peterson, Lyndon M. Foster, Paul Brian